Hybrid-closed loop Part 1 of 3: Overview of hybrid closed loops - key concepts, options available and choosing the right system

Overview of hybrid closed loops - key concepts, options available and choosing the right system

Wednesday 21st July 2021, 17.00 - 18.30

 

 

In anticipation of wider hybrid-closed loop (also known as artificial pancreas systems) use in the NHS and NHSE hybrid-closed loop pilot, ABCD DTN in collaboration with King's Health Partners will be offering a series of 3 live webinars. These will cover aspects relevant to healthcare professional using these novel systems in clinic. 

The first part of this 3 series interactive webinar that will cover basic aspects of hybrid closed-loop systems . It will include details of systems available in the UK, key concepts of how they work and overview of practical aspects relevant to using these systems in clinics.  It is open to all NHS healthcare professionals caring for people with type 1 diabetes in the UK. 

Please join us and contribute to the live Q&A. Details for the remaining 2 webinars will be announced soon. 

Places will be allocated on first come first serve basis. Previous similar courses on this topic have sold out within days and therefore register soon to avoid disappointment.

 

 

Speakers

  • Mrs. Geraldine Gallen

    image of Mrs. Geraldine Gallen

    Senior Diabetes Specialist Nurse

    Geraldine Gallen Type 1 Service Lead, Senior Diabetes Specialist Nurse Kings College Hospital, London Geraldine Gallen is a Senior Diabetes Specialist Nurse, currently working at Kings College Hospital, London. She has been in this position for over ten years and is the lead for the Type 1 diabetes service. Geraldine’s main clinical interest is in the management and education of all patients with Type 1 diabetes including those patients experiencing problematic hypoglycaemia, and along with the team at Kings offers a full range of treatments including structured education, DAFNE and DAFNE for pumpers, technology including insulin pump therapy, sensor augmented pump therapy, automated closed loop systems, continuous glucose monitoring and flash glucose monitoring. She and her team have over 800 patients on insulin pumps and over 300 patients funded on full time continuous glucose monitoring. Geraldine has also had training in Cognitive Behavioural therapy (CBT) and Motivational Interviewing (MI) and is interested in developing these skills further and supporting patients in their holistic management with their diabetes. Geraldine is excited by the developments of technology within type 1 diabetes management and can often be found talking to patients and healthcare professionals nationally and internationally educating how technology can be adapted into the patient pathway.

  • Dr. Sufyan Hussain

    image of Dr. Sufyan Hussain

    consultant

    Dr Sufyan Hussain is a Consultant Diabetologist at Guy’s and St Thomas Hospital and Honorary Senior Clinical Lecturer at King’s College London. He has a specialist interest in the application of diabetes technologies and novel therapies, including cell therapy, in diabetes. He graduated from the University of Cambridge and undertook specialist training in London. He completed his PhD in molecular neuro-physiology under Sir Prof Stephen Bloom at Imperial College and was a visiting scholar at Joslin Diabetes Centre, Harvard Medical School. As a Darzi fellow in Clinical Leadership he worked on projects related to integrated care and digital health. He is a committee member of ABCD Diabetes Technology Network, NHSE London Diabetes Strategic Clinical Network, JDRF Scientific Advisory Committee, Open EU consortium, Secretary of State for Transport’s Honorary Medical Advisory Panel on driving and Diabetes Mellitus and is the lead specialist committee member for the NICE multiple technology appraisal on hybrid closed loops. His current research interests in type 1 diabetes include automated insulin delivery systems, application cell therapy in diabetes, mental health and hypoglycaemia awareness, metabolic effects of fasting and impact of health inequalities on outcomes using diabetes technologies. He has over 30 years personal experience of living with type 1 diabetes and is passionate about improving care for diabetes.

ABCD Corporate Pharma Sponsors

Gold

  • AstraZeneca UK
  • Boehringer Ingelheim and Lilly Alliance
  • Eli Lilly and Company

Silver

  • A Menarini Farmaceutica Internazionale SRL

ABCD Corporate Pump & Device Sponsors

Gold

  • Abbott
  • Dexcom
  • Ypsomed Ltd

Silver

  • Air Liquide Healthcare Ltd
  • Insulet International
  • Medtronic Limited

Contact

Address for correspondence: 
ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602
Email: info@abcd.care

Follow Us

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE  Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE . ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd